XML 41 R28.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-based Compensation (Tables)
9 Months Ended
Sep. 30, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-based Compensation Expense Recognized

Stock‑based compensation expense recognized was as follows (in thousands):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Research and development

 

$

43

 

 

$

13

 

 

$

62

 

 

$

42

 

General and administrative

 

 

68

 

 

 

56

 

 

 

156

 

 

 

147

 

Total stock-based compensation expense

 

$

111

 

 

$

69

 

 

$

218

 

 

$

189

 

Weighted-Average Assumptions used in Estimating Fair Value of each Stock Options using Black-Scholes Option-Pricing Model

The fair value of each stock option was estimated using the Black‑Scholes option‑pricing model with the following weighted-average assumptions:

 

 

 

Nine Months Ended September 30,

 

 

 

2020

 

 

2019

 

Risk-free interest rate

 

 

0.49

%

 

 

1.58

%

Expected volatility

 

 

80.11

%

 

 

74.59

%

Expected term (in years)

 

 

6.93

 

 

 

6.59

 

Expected dividend yield

 

 

 

 

 

 

 

Summary of Option Activity

A summary of option activity for the nine months ended September 30, 2020 was as follows:

 

 

 

Available

for Grant

 

 

Shares

 

 

Weighted-

Average

Exercise

price

per Share

 

 

Weighted-

Average

Remaining

Contractual

Term

(in years)

 

 

Aggregate

Intrinsic

Value

(in

thousands)

 

Balance at December 31, 2019

 

 

399,737

 

 

 

1,514,770

 

 

$

1.03

 

 

7.16

 

 

$

500

 

Authorized

 

 

4,343,534

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

(994,293

)

 

 

994,293

 

 

 

16.20

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

 

(540,334

)

 

 

1.00

 

 

 

 

 

 

 

 

 

Forfeited/expired

 

 

41,301

 

 

 

(41,301

)

 

 

1.35

 

 

 

 

 

 

 

 

 

Balance at September 30, 2020

 

 

3,790,279

 

 

 

1,927,428

 

 

$

8.85

 

 

 

8.18

 

 

$

18,521

 

Expected to vest

 

 

 

 

 

 

1,298,059

 

 

$

12.71

 

 

 

9.52

 

 

$

7,460

 

Options exercisable

 

 

 

 

 

 

629,373

 

 

$

0.89

 

 

 

5.43

 

 

$

11,061

 

 

Summary of Stock Options Outstanding and Exercisable

Stock options outstanding and exercisable consisted of the following at September 30, 2020:

 

 

 

Employees and Directors

 

 

Non-employees

 

Exercise Price ($)

 

Shares

Outstanding

 

 

Shares

Exercisable

 

 

Shares

Outstanding

 

 

Shares

Exercisable

 

0.16

 

 

75,660

 

 

 

75,660

 

 

 

12,611

 

 

 

12,611

 

0.48

 

 

162,353

 

 

 

162,353

 

 

 

 

 

 

 

1.00

 

 

 

 

 

 

 

 

37,830

 

 

 

37,830

 

1.04

 

 

70,933

 

 

 

70,933

 

 

 

31,525

 

 

 

31,525

 

1.19

 

 

52,645

 

 

 

38,878

 

 

 

34,677

 

 

 

34,677

 

1.31

 

 

63,050

 

 

 

63,050

 

 

 

 

 

 

 

1.35

 

 

294,754

 

 

 

27,529

 

 

 

116,642

 

 

 

63,049

 

1.49

 

 

31,525

 

 

 

10,508

 

 

 

 

 

 

 

17.00

 

 

747,770

 

 

 

770

 

 

 

195,453

 

 

 

 

Total

 

 

1,498,690

 

 

 

449,681

 

 

 

428,738

 

 

 

179,692

 

 

Summary of RSA Activity

A summary of RSA activity for the nine months ended September 30, 2020 was as follows:

 

 

 

Share

Equivalent

 

 

Weighted-

Average

Grant Date

Fair Value

 

Non-vested at December 31, 2019

 

 

8,407

 

 

 

1.35

 

Granted

 

 

 

 

 

 

Vested

 

 

(4,203

)

 

 

1.35

 

Non-vested at September 30, 2020

 

 

4,204

 

 

$

1.35